Dec 11 (Reuters) - Shares of Certara Inc rose nearly 30% in their debut on Friday, giving the drug development consultancy company a market capitalization of $4.56 billion. The company’s shares opened at $29.9, above its initial public offering price of $23 apiece at which it raised about $670 million.
مشاركة :